Award

Azv Nw26-03-00152

Funder: Agentura Pro Zdravotnický Výzkum České Republiky

Funded outputs count: 1

Funder award ID: AZV NW26-03-00152

OpenAlex ID: G6921504388

A murine proof-of-concept study of polatuzumab vedotin in combination with venetoclax in experimental therapy of BCL2-positive aggressive lymphomas

2026 · Eva Pokorna, Dmitry Manakov, et al. · Scientific Reports